Related Experiment Video
Updated: Jun 25, 2025

A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19
Published on: July 5, 2022
Screening for Nephropathy in Pediatric Type 2 Diabetes: Quality Improvement to Increase Nephropathy Screening
Elizabeth A Mann1, Kelsi Alexander1, Whitney Beaton2
1From the Department of Pediatrics, University of Wisconsin School of Medicine and Public Health, Madison, Wisc.
Insights
Early screening for kidney disease in youth with type 2 diabetes is crucial. A quality improvement initiative successfully increased and sustained urine nephropathy screening rates in pediatric patients.
Area of Science:
- Pediatric Nephrology
- Endocrinology
- Quality Improvement Science
Background:
- Microalbuminuria screening is vital for early kidney disease detection in youth-onset type 2 diabetes.
- Standardizing screening protocols is essential at the time of diagnosis.
- A quality improvement initiative targeted pediatric type 2 diabetes patients at a tertiary academic medical center.
Purpose of the Study:
- To standardize urine nephropathy screening in pediatric patients with type 2 diabetes.
- To increase the baseline screening rate from 56% to 75% within 6 months.
- To sustain the increased screening rate for an additional 6 months.
Main Methods:
- Employed quality improvement methods and iterative Plan-Do-Study-Act cycles.
- Implemented interventions including previsit planning, education, and a new-onset triage protocol.
- Collected data through electronic medical record reviews, measuring screening rates at clinic visits.
Main Results:
- Urine nephropathy screening rates increased from a baseline of 56% to 75%.
- This significant increase was sustained for the subsequent 6-month period.
- The study involved 121 youth with type 2 diabetes, with a mean age of 14.5 years.
Conclusions:
- Interventions focused on efficient screening identification and coordinated processes improved screening rates.
- Shared understanding among stakeholders and practical healthcare system support were key to success.
- The initiative demonstrated sustained improvement in urine nephropathy screening for pediatric type 2 diabetes patients.
Background:
Screening for early detection of microalbuminuria signaling kidney disease should begin as early as the time of diagnosis of youth-onset type 2 diabetes. This quality improvement initiative aimed to standardize urine nephropathy screening in pediatric patients with type 2 diabetes at a tertiary academic medical center and increase a baseline screening rate of 56%-75% over 6 months (September 2022-February 2023) and sustain that increase for 6 months (March through August 2023).
Methods:
A multi-disciplinary team used quality improvement methods and iterative Plan-Do-Study-Act cycles. Targeted interventions included previsit planning workflow, education, and a new-onset triage protocol. The team collected data at baseline and prospectively by reviewing electronic medical records. The primary outcome measure was pediatric type 2 diabetes clinic visits in diabetes clinic with urine nephropathy screening before or on the visit date.
Results:
A total of 121 youth were scheduled for T2D clinic visits between September 2021 and August 2023. The mean age was 14.5 years, and 60% were women, 40% were non-Hispanic Black, 28% were Hispanic/Latino, and 15% reported Spanish as their preferred language. Following the interventions of this project, urine nephropathy screening increased from 56% to 75%, and this change was sustained for 6 months.
Conclusions:
Interventions focused on efficient recognition of the population needing screening, coordinated internal processes around screening, a shared understanding between all stakeholders, and practical support in the healthcare system increased urine nephropathy screening with sustained improvement.
Related Concept Videos
Diabetes: Symptoms, Diagnosis, and Complications
Diabetes: Management and Pharmacotherapy
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Factors Affecting Renal Clearance: Renal Impairment
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...

